Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duloxetine 60 to 120 mg Once Daily Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder

NCT00122863 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00122863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00122863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duloxetine 60 to 120 mg Once Daily Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
March 31, 2007
Enrollment
380
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders